In the absence of instruction from the Annual General Meeting 2015, a group of
shareholders representing over 30% of the shares and votes in the Company, as of
January 22, 2016, jointly together with the Board of Directors, appointed a
nomination committee for the AGM 2016 and drafted a charter for its work.
The Nomination Committee consists of representatives of the three largest
shareholders as of January 26, 2016, these are Henrik Blomquist (Chairman),
representing Bure Equity AB (publ), Anders Spetz, representing Soliver Ltd and
Mikael Karlsson as the representative of the family Karlsson (Cecilia and Amanda
Karlsson).
It was further resolved that the Company’s Chairman of the Board shall be a
member and secretary of the committee.
The Nomination Committee is to present to the Annual General Meeting 2016
proposals for: (1) The chairman of the meeting, (2) the composition of the Board
and Board members, (3) chairman and auditor(s) in the Company, and (4) their
fees. The Election Committee shall represent and take all shareholders’
interests into consideration.
Shareholders wishing to submit proposals to Vigmed Holding AB’s Nomination
Committee are welcome to do so via e-mail to: henrik.blomquist@bure.se. Or
through regular mail to: Vigmed AB, Attention: Nomination Committee,
Garnisonsgatan 10 , 254 66 Helsingborg, Sweden. At the latest: February 29,
2016.
________________________________
Helsingborg January 29, 2016
Vigmed Holding AB (publ)
The Nomination Committee
For further information contact:
Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Henrik Olsen +46 76
349 7364
Vigmed is a Swedish medical technology company whose mission is to eliminate
needlestick injuries and the associated risk of cross infections with blood
-borne infectious diseases by offering the market unique needle-protected
products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is
traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has
approximately 5 500 shareholders. Remium Nordic AB is the Company’s Certified
Advisor. Additional information about the company can be found on Vigmed’s
website: www.vigmed.com/investor
